Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma
Abstract Pulmonary Sarcomatoid Carcinoma (PSC) constitutes a heterogeneous group of non-small-cell lung carcinomas (NSCLCs) with a poor prognosis. In this study, a group of 7 patients with PSC was studied. Microscope analysis of all 7 cases revealed a pleomorphic carcinoma subtype. Moreover, 5 cases...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f255ce762154ad9ae0a37828e1def78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7f255ce762154ad9ae0a37828e1def78 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7f255ce762154ad9ae0a37828e1def782021-12-02T15:05:10ZClinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma10.1038/s41598-017-04296-22045-2322https://doaj.org/article/7f255ce762154ad9ae0a37828e1def782017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04296-2https://doaj.org/toc/2045-2322Abstract Pulmonary Sarcomatoid Carcinoma (PSC) constitutes a heterogeneous group of non-small-cell lung carcinomas (NSCLCs) with a poor prognosis. In this study, a group of 7 patients with PSC was studied. Microscope analysis of all 7 cases revealed a pleomorphic carcinoma subtype. Moreover, 5 cases (71.4%) were composed entirely of malignant sarcomatoid-like elements, and 2 cases (28.6%) were composed of malignant sarcomatoid-like elements and at least 10% adenocarcinoma-like elements. Immunohistochemically, the PSC components of all 7 cases were positive for vimentin and cytokeratins, including cytokeratin (CK) and cytokeratin 7 (CK7). Next-Generation Sequencing (NGS) was performed, and a total of 136 putative somatic variants and one gene fusion were identified, of which 16 variants were considered hot spot mutations, including the genes EGFR, EML4-ALK, MET, BRAF, PIK3CA, and TP53. Of these hot spot mutations, one sample expressing an EML4-ALK fusion was further confirmed by Ventana IHC, and one sample containing an EGFR exon 19 deletion was also confirmed. The NGS results imply that TP53 mutations occur often in PSCs and that EML4-ALK fusion events and EGFR exon deletions also occur in these rare tumors. Molecular targeted therapy may be a useful treatment strategy for these rare lung tumors.Xin LiDan WangQingchun ZhaoDian RenFan RenGang ChenHongyu LiuJun ChenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Xin Li Dan Wang Qingchun Zhao Dian Ren Fan Ren Gang Chen Hongyu Liu Jun Chen Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma |
description |
Abstract Pulmonary Sarcomatoid Carcinoma (PSC) constitutes a heterogeneous group of non-small-cell lung carcinomas (NSCLCs) with a poor prognosis. In this study, a group of 7 patients with PSC was studied. Microscope analysis of all 7 cases revealed a pleomorphic carcinoma subtype. Moreover, 5 cases (71.4%) were composed entirely of malignant sarcomatoid-like elements, and 2 cases (28.6%) were composed of malignant sarcomatoid-like elements and at least 10% adenocarcinoma-like elements. Immunohistochemically, the PSC components of all 7 cases were positive for vimentin and cytokeratins, including cytokeratin (CK) and cytokeratin 7 (CK7). Next-Generation Sequencing (NGS) was performed, and a total of 136 putative somatic variants and one gene fusion were identified, of which 16 variants were considered hot spot mutations, including the genes EGFR, EML4-ALK, MET, BRAF, PIK3CA, and TP53. Of these hot spot mutations, one sample expressing an EML4-ALK fusion was further confirmed by Ventana IHC, and one sample containing an EGFR exon 19 deletion was also confirmed. The NGS results imply that TP53 mutations occur often in PSCs and that EML4-ALK fusion events and EGFR exon deletions also occur in these rare tumors. Molecular targeted therapy may be a useful treatment strategy for these rare lung tumors. |
format |
article |
author |
Xin Li Dan Wang Qingchun Zhao Dian Ren Fan Ren Gang Chen Hongyu Liu Jun Chen |
author_facet |
Xin Li Dan Wang Qingchun Zhao Dian Ren Fan Ren Gang Chen Hongyu Liu Jun Chen |
author_sort |
Xin Li |
title |
Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma |
title_short |
Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma |
title_full |
Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma |
title_fullStr |
Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma |
title_full_unstemmed |
Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma |
title_sort |
clinical significance and next-generation sequencing of chinese pulmonary sarcomatoid carcinoma |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/7f255ce762154ad9ae0a37828e1def78 |
work_keys_str_mv |
AT xinli clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma AT danwang clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma AT qingchunzhao clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma AT dianren clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma AT fanren clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma AT gangchen clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma AT hongyuliu clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma AT junchen clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma |
_version_ |
1718388900888576000 |